Beijing, 13 August 2026 – China is accelerating the development of brain-computer interfaces through coordinated initiatives involving state-owned insurers, investment institutions and local governments, signalling a shift from laboratory research toward clinical and commercial deployment.
Brain-computer interfaces connect neural activity with external devices and could support treatment or assistance for patients with neurological conditions. The sector remains technically demanding and ethically sensitive, particularly when devices require invasive surgery, but China’s policy mobilisation is beginning to address risks that sit beyond pure scientific research.
Unlock the Full Article
This article is exclusive to The Ledger Asia Subsribers / PAID members.
Already have an account? Log in here